Organisation paid for research Program year 2025 Source: CMS Open Payments

Thomas Eye Group PC

Neither a doctor nor a teaching hospital

Research payments

$174,357

33 payments

Through program year 2025, Thomas Eye Group PC is reported as receiving $174,357 in research payments, across 33 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$42,791	9
2024	Research	$53,312	10
2023	Research	$54,447	10
2022	Research	$23,807	4

Breakdown

Who paid Research payments · program years 2022–2025

AbbVie, Inc. $174,357 33 payments

Studies the money was for Research payments · program years 2022–2025

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $119,622 27 payments
1698-301-007 Ph3b Study (M21-488) $22,063 1 payment
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension $21,137 1 payment
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $5,784 3 payments
SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension $5,750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.